Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic

Fungal pathogens cause an array of diseases by targeting both immunocompromised and immunocompetent hosts. Fungi overcome our current arsenal of antifungals through the emergence and evolution of resistance. In particular, the human fungal pathogen, <i>Cryptococcus neoformans</i> is foun...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ben Muselius, Shay-Lynn Durand, Jennifer Geddes-McAlister
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/27779c36e7b24c5a8e4b390eeb49ba93
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:27779c36e7b24c5a8e4b390eeb49ba93
record_format dspace
spelling oai:doaj.org-article:27779c36e7b24c5a8e4b390eeb49ba932021-11-25T17:56:11ZProteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic10.3390/ijms2222123901422-00671661-6596https://doaj.org/article/27779c36e7b24c5a8e4b390eeb49ba932021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12390https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Fungal pathogens cause an array of diseases by targeting both immunocompromised and immunocompetent hosts. Fungi overcome our current arsenal of antifungals through the emergence and evolution of resistance. In particular, the human fungal pathogen, <i>Cryptococcus neoformans</i> is found ubiquitously within the environment and causes severe disease in immunocompromised individuals around the globe with limited treatment options available. To uncover fundamental knowledge about this fungal pathogen, as well as investigate new detection and treatment strategies, mass spectrometry-based proteomics provides a plethora of tools and applications, as well as bioinformatics platforms. In this review, we highlight proteomics approaches within the laboratory to investigate changes in the cellular proteome, secretome, and extracellular vesicles. We also explore regulation by post-translational modifications and the impact of protein–protein interactions. Further, we present the development and comprehensive assessment of murine models of cryptococcal infection, which provide valuable tools to define the dynamic relationship between the host and pathogen during disease. Finally, we explore recent quantitative proteomics studies that begin to extrapolate the findings from the bench to the clinic for improved methods of fungal detection and monitoring. Such studies support a framework for personalized medical approaches to eradicate diseases caused by <i>C. neoformans</i>.Ben MuseliusShay-Lynn DurandJennifer Geddes-McAlisterMDPI AGarticle<i>Cryptococcus neoformans</i>mass spectrometry-based proteomicsfungal pathogenesisin vitro and in vivo modelspersonalized medicineBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12390, p 12390 (2021)
institution DOAJ
collection DOAJ
language EN
topic <i>Cryptococcus neoformans</i>
mass spectrometry-based proteomics
fungal pathogenesis
in vitro and in vivo models
personalized medicine
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle <i>Cryptococcus neoformans</i>
mass spectrometry-based proteomics
fungal pathogenesis
in vitro and in vivo models
personalized medicine
Biology (General)
QH301-705.5
Chemistry
QD1-999
Ben Muselius
Shay-Lynn Durand
Jennifer Geddes-McAlister
Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic
description Fungal pathogens cause an array of diseases by targeting both immunocompromised and immunocompetent hosts. Fungi overcome our current arsenal of antifungals through the emergence and evolution of resistance. In particular, the human fungal pathogen, <i>Cryptococcus neoformans</i> is found ubiquitously within the environment and causes severe disease in immunocompromised individuals around the globe with limited treatment options available. To uncover fundamental knowledge about this fungal pathogen, as well as investigate new detection and treatment strategies, mass spectrometry-based proteomics provides a plethora of tools and applications, as well as bioinformatics platforms. In this review, we highlight proteomics approaches within the laboratory to investigate changes in the cellular proteome, secretome, and extracellular vesicles. We also explore regulation by post-translational modifications and the impact of protein–protein interactions. Further, we present the development and comprehensive assessment of murine models of cryptococcal infection, which provide valuable tools to define the dynamic relationship between the host and pathogen during disease. Finally, we explore recent quantitative proteomics studies that begin to extrapolate the findings from the bench to the clinic for improved methods of fungal detection and monitoring. Such studies support a framework for personalized medical approaches to eradicate diseases caused by <i>C. neoformans</i>.
format article
author Ben Muselius
Shay-Lynn Durand
Jennifer Geddes-McAlister
author_facet Ben Muselius
Shay-Lynn Durand
Jennifer Geddes-McAlister
author_sort Ben Muselius
title Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic
title_short Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic
title_full Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic
title_fullStr Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic
title_full_unstemmed Proteomics of <i>Cryptococcus neoformans</i>: From the Lab to the Clinic
title_sort proteomics of <i>cryptococcus neoformans</i>: from the lab to the clinic
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/27779c36e7b24c5a8e4b390eeb49ba93
work_keys_str_mv AT benmuselius proteomicsoficryptococcusneoformansifromthelabtotheclinic
AT shaylynndurand proteomicsoficryptococcusneoformansifromthelabtotheclinic
AT jennifergeddesmcalister proteomicsoficryptococcusneoformansifromthelabtotheclinic
_version_ 1718411790780465152